Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
Online payments provider and buy-now-pay-later (BNPL) lender Klarna has become “the latest... casualty” in the initial public offering (IPO) market following the announcement on tariffs, say Ben Dummett and Joe Wallace in The Wall Street Journal. It has decided to postpone its flotation. It was due to launch a marketing campaign for the listing on the New York Stock Exchange, where it has been targeting a valuation of $15 billion – over double the $6.7 billion it was worth in 2022. Rival Affirm’s market valuation dropped 15% on Friday 4 April. It has almost halved to $12 billion this year.
The dismal performance of Affirm and its other rivals may have played a big role in Klarna having “second thoughts” about entering the stock market, says Pymnts. However, there are also some “larger concerns”. The trade war unleashed by Donald Trump could cause consumers to “throttle” overall spending. This would be particularly bad news for Klarna, which makes its money from short-term loans to consumers. What’s more, during bear markets, investors tend to focus on companies with a “prolonged history of operating profits”, while Klarna admitted in recent pre-flotation filings that operating losses had instead “been widening at the company”.
Is Klarna a prudent lender?
The evidence suggests that Klarna’s ability to make loans wisely isn’t as great as it might seem, adds Stephen Gandel for Breakingviews. While its headline loan-loss rate is only 0.47%, far lower than the 5.2% banks have been forced to write off on credit-card loans, it has set aside $495 million to cover potential unpaid debt from consumers. Using an alternative measure, Klarna’s loan losses are actually “slightly worse” than the industry average at 5.5% of outstanding balances. While Klarna’s customers do pay off their instalment loans more quickly, it is not clear that Klarna’s business model is really different from that of banks, so investors could be forgiven for giving it a “more bank-like valuation” rather than treating it like “a high-growth company”.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Sweden’s Klarna is the “new kid on the block” when it comes to BNPL in the US, says Theodora Lee Joseph in Finimize. This can be positive: the US market is much less developed than the European one, with a mere 9.8% of consumers using BNPL, compared with 20% in the UK and 33% in Germany. But competition in America is more intense, with Affirm and PayPal “vying for market share” too. Many US firms offer BNPL “as a free add-on”, which is another challenge. Klarna “might have to sacrifice margin to stay competitive”.
Still, Klarna isn’t the only company that has decided to delay a US listing for now, says the Financial Times. Ticketing company StubHub, virtual physical-therapy company Hinge Health and Israel-based trading platform eToro have, too. This marks a “stark turnaround” from expectations at the start of the year that the IPO market “would boom under an ostensibly pro-business Republican administration”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
Premium Bonds quiz: How much do you know about the NS&I savings product?Quiz Many savers choose Premium Bonds in the hopes of winning a prize in the monthly draws. How much do you know about the savings product?
-
UK dividends rose in final quarter of 2025, but share buybacks ate into investor payoutsLast year saw dividend growth continue to fall below pre-pandemic averages, against a backdrop of increasing share buybacks.
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust